Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. - Wikidata - awgldk - TriplyDB

Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

http://www.wikidata.org/entity/Q34984257

about

E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1 Kruppel-like factor 15 is critical for vascular inflammation microRNA-200b as a Switch for Inducible Adult Angiogenesis Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway Systems biology of vascular endothelial growth factors E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.Contrasting roles of E2F2 and E2F3 in cardiac neovascularization.DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors.PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice.Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis.Rosuvastatin enhances angiogenesis via eNOS-dependent mobilization of endothelial progenitor cells.Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression.Emerging roles of E2Fs in cancer: an exit from cell cycle control Gli3 regulation of myogenesis is necessary for ischemia-induced angiogenesis Coordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice.Murine double minute-2 expression is required for capillary maintenance and exercise-induced angiogenesis in skeletal muscle.MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia.Regenerative repair of Pifithrin-α in cerebral ischemia via VEGF dependent manner.Prediction of Cis-Regulatory Elements Controlling Genes Differentially Expressed by Retinal and Choroidal Vascular Endothelial Cells.Role of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interaction.Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC.IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects.Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.MicroRNA let-7g possesses a therapeutic potential for peripheral artery disease.Hypoxia pathway and hypoxia-mediated extensive extramedullary hematopoiesis are involved in ursolic acid's anti-metastatic effect in 4T1 tumor bearing mice A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke Hypoxia-regulated angiogenic inhibitors.E2F and microRNA regulation of angiogenesis.p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway.Rad18 is a transcriptional target of E2F3.The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.Proteomic identification of the wt-p53-regulated tumor cell secretome.HIF proteins connect the RB-E2F factors to angiogenesis.

P2860

Q24296966-2AE697CD-4067-4F27-9B34-A65A4C71763A Q24321728-93AED467-2404-495B-AD7B-AE992A82A9BB Q28080485-754DFE35-53D7-4CBC-8D3C-8A1A6645D6DA Q28383324-48EFB529-2D81-4382-9F07-BDD219BECE78 Q28587353-3A1F18CD-1016-4235-9DFE-14DF63C39C11 Q30413602-1A4E023D-D24E-4609-B123-3242E1D5E019 Q30438979-CD4FD94A-C242-4100-937F-E8CB8599819E Q30564026-605442D8-64FF-4C30-ABE8-6CD6D9D0369D Q31120422-651EE3F3-604E-4921-A3C5-C0770243877B Q33787360-84019AAF-4C7E-469A-8959-039CDC5DF7CB Q33794153-24843372-2CC0-4EAC-BD91-50604F1BFB3D Q33826204-8B017E61-3104-45C9-908A-3B424FD79FD9 Q33919479-361096B9-92A7-4C14-AEF1-1DD0CF46B73B Q34679389-895521ED-DDF9-493A-9878-3A5C6B48DDBB Q34737352-37A29E7A-3095-40D4-A558-DF39A044A568 Q34799489-211197EE-9B4F-412C-81C0-71A44680368E Q34974493-25C61E5B-9054-46E3-AF66-B3C8BF8AB6D8 Q35009182-0018AB79-7627-488A-BF02-B2A6064EFD1F Q35117261-6F878A3A-DD15-4DD8-B273-764D9CB6B810 Q36216091-70464653-D669-4EBD-94FF-69A0FAE0FE65 Q36329784-D90A3366-9758-4B85-A1D8-E121873D427D Q36739746-448E0215-65E6-4F6A-827B-D12F8931CE88 Q36925077-1CBCEA1B-A1F9-40C1-B372-48583458053C Q36950134-EFEA09B5-ADDE-4AB1-A020-D4CA4694035A Q37227786-CADDE781-1828-4499-B3AD-FDB68E62E8D0 Q37372976-37273E3D-ED0F-4832-BA64-EE4917380074 Q37392876-CFF4D5EE-2A79-4C62-9472-DE50B819DDCA Q37415365-E8114CF3-CEE2-4A3F-8AE7-73F3D557D099 Q37436763-5FBBADD8-6245-4E3E-8716-3D7F0D144BD9 Q37445515-CD35B393-4FF7-46A3-9738-F4C2C96B7C84 Q37662841-8C6B30AD-0893-4845-B787-B31F3C538F38 Q37687717-4CC3EEB6-08CF-4403-87EB-B6B01DC0D183 Q37738215-C5DF4102-D970-4D30-B8EB-55B99BE8923E Q37743975-A4168A33-D1B1-4578-8544-73D23DC434A4 Q37971391-AD35FA87-4D33-4F83-8815-0A1D959D6775 Q39187173-1BA14E0A-8874-4CF5-B793-96C91B2FD99C Q39385329-3C7718E4-7EB1-4CC0-963E-4FE5FA2966A2 Q39794563-E4703DC3-010E-4C5B-9F32-182C8D035AA6 Q40219883-90E572D6-33EF-4E23-9FB9-AC81A12DF722 Q40456760-2594088F-1A7F-4AFD-90E4-7C840C41C81B

P2860

Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

http://www.wikidata.org/entity/Q34984257

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@ast

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@en

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@nl

type

label

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@ast

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@en

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@nl

prefLabel

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@ast

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@en

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@nl

P1433

Q34984257-585AC024-5EE0-4F11-B57F-D55CC0981AFA

P1476

Q34984257-35F5B349-653C-4DE0-99D3-641982FEB08C

P2093

Q34984257-06AD8913-A426-46D9-9F5F-10012FBFC34E

Q34984257-0F649ECC-7FCD-4BFD-8E4B-888EE4E03B3D

Q34984257-337B73BC-32BF-4F76-8460-2652FD49AB0A

Q34984257-337EEFE4-8DEA-426D-9554-F81084450D8C

Q34984257-3455D6CB-DDEE-4119-B6B9-BF86BD6FC508

Q34984257-4348D217-0C43-4F45-9F64-8884AE26E54A

Q34984257-6BB4E0D5-7EC2-4743-A158-1E7B6280B038

Q34984257-7321A130-14CB-4261-8868-2BD34EF23184

Q34984257-88627749-0BEB-402E-9FFB-F62EEE06B0D4

Q34984257-8DC5B5EC-FB57-4C84-A1F3-A8E11FDBD86C

P2860

Q34984257-00133677-CE82-4E2B-A455-AA505155E671

Q34984257-024482E2-88D7-4255-815E-411C09A1FE65

Q34984257-0DE4B1E3-D522-4010-8CE0-A716E405FD94

Q34984257-1909F53C-EDF8-43F5-8926-DF2BEA161AC2

Q34984257-1A68320E-A678-4928-B67E-2AAD1120027F

Q34984257-1B7EBEF9-762B-4BEA-B685-41367E1762BB

Q34984257-1CB15315-6C13-4F17-91DA-AEABE0BE7368

Q34984257-26E9C457-4628-4BE9-94CF-82C8E03CA324

Q34984257-28E765BE-651E-43EC-A18B-5C2CEAC15FE7

Q34984257-36402C83-D64D-48F7-BD77-21ABCCF7D3E6

P304

Q34984257-7959A319-85A0-488B-894C-679E9359DBF8

P31

Q34984257-38E43CE9-2774-4149-B05F-356B5F9FEA19

P356

Q34984257-2A2A8A5F-A46E-43B7-887C-134288D78399

P407

Q34984257-C39B05AA-3A25-4A7B-B990-F9D3C8747981

P433

Q34984257-767A07F7-0785-4CBC-B871-BEA865A7D039

P478

Q34984257-6BC1D483-FA5A-407D-985E-F9DF4C89BEC3

P577

Q34984257-86A1B3F8-9ABA-46CB-8195-8CB5B2352FDB

P5875

Q34984257-8683D04F-1986-4032-9527-A221342DFE1D

P698

Q34984257-BAA95C3D-F460-47F5-A7DD-1498AE4E3029

P932

Q34984257-3E1F97D0-7000-4333-9AC0-878F2AB949E8

P356

PNAS.0509533103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Cell cycle regulator E2F1 modu ...... anscriptional control of VEGF.

@en

P2093

Allison Hanley

http://www.w3.org/2001/XMLSchema#string

Andrea Wecker

http://www.w3.org/2001/XMLSchema#string

Christine M Dolan

http://www.w3.org/2001/XMLSchema#string

Corinne N Luedemann

http://www.w3.org/2001/XMLSchema#string

Cynthia Curry

http://www.w3.org/2001/XMLSchema#string

David A Goukassian

http://www.w3.org/2001/XMLSchema#string

Deepika Dinesh

http://www.w3.org/2001/XMLSchema#string

Douglas W Losordo

http://www.w3.org/2001/XMLSchema#string

Fabio Martelli

http://www.w3.org/2001/XMLSchema#string

Gangjian Qin

http://www.w3.org/2001/XMLSchema#string

P2860

bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha

Tumor angiogenesis: therapeutic implications

Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha

Vascular-specific growth factors and blood vessel formation

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells.

Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.

Mouse model of angiogenesis

Context-dependent transcriptional regulation.

P304

11015-11020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0509533103

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6950937

http://www.w3.org/2001/XMLSchema#string

P698

16835303

http://www.w3.org/2001/XMLSchema#string

P932

1544166

http://www.w3.org/2001/XMLSchema#string